Nov 05 2024 25 mins
Our third entry of "Best of UEG Week 2024" is all about "bench to bedside" world-class science!
Interviewed by Julia Mayerle, Maria Del Pilar Acedo Nunez and Juozas Kupčinskas reflect on their highlights of the UEG Week 2024.
Sessions and abstracts mentioned:
- Microbiota in diagnostics @03:35
- Microbiome: Bench to the future @03:35
- Pancreatic diseases: From mechanisms to therapy @04:05
- Session: IBD: Latest news on a personalised approach @05:25
- Session: Diagnose and treat to target in GI cancer: Latest news @05:25
- Pancreatic cancer: From bench to bedside @06:45
- FECAL MICROBIOTA TRANSPLANT VERSUS VANCOMYCIN FOR PRIMARY CLOSTRIDIODES DIFFICILE INFECTION – A RANDOMIZED NON-INFERIORITY TRIAL @08:50
- TARGETED FECAL MICROBIOTA TRANSPLANTATION IN PATIENTS RECEIVING PEMBROLIZUMAB PLUS AXITINIB FOR METASTATIC RENAL CELL CARCINOMA: PRELIMINARY RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (TACITO TRIAL) @09:05
- CROHN'S DISEASE AND ULCERATIVE COLITIS EXHIBIT PRE-DIAGNOSTIC ANTIBODY SIGNATURES WITH SHARED AND DIVERGENT CHANGES TOWARDS DISEASE ONSET @10:30
- Session: Understanding disease primers of IBD: Part 1
- Session: Understanding disease primers of IBD: Part 2
- Targeting kRAS in GI cancer @13:30
- SINGLE-NUCLEUS RNA SEQUENCING REVEALS THE CRUCIAL ROLE OF TERTIARY LYMPHOID STRUCTURES IN DRIVING B CELL MATURATION INTO PLASMA CELLS IN PDAC @14:30
- Never waste a good disaster: HPB @18:20